Radioiodine therapy: a dosimetric study in a patient with DTC after rhTSH stimulation

被引：0
|
作者：
Mazzaglia, S. [1 ,2 ]
Tonghi, L. Barone [2 ]
Gueli, A. M. [1 ,3 ]
Tuve, C. N. [1 ,3 ]
Pellegriti, G. [1 ,4 ]
机构：
[1] Univ Catania, Dept Med Surg & Adv Technol GF Ingrassia DGFI, Specializat Sch Med Phys, Catania, Italy
[2] ARNAS Garibaldi Catania, Med Phys, Catania, Italy
[3] Univ Catania, Deparment Phys & Astron, Catania, Italy
[4] ARNAS Garibaldi Catania, Endocrinol, Catania, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1016/S0167-8140(19)32193-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1773
引用
收藏
页码：S958 / S958
页数：1
相关论文
共 50 条
  • [31] Evaluation of Radioiodine Therapy with an Adapted Dosimetric Approach in Patients with Hyperthyroidism
    Fernandes, A.
    Faria, T.
    Coelho, P.
    Casalta-Lopes, J.
    Oliveira, A.
    Alves, V.
    Pinto, A.
    Perez, M.
    Vieira, T.
    Pereira, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S768 - S769
  • [32] Reduced fear of radioactivity and isolation after in patient radioiodine therapy (RIT)
    von Mueller, F.
    Happel, C.
    Etzel, M.
    Sauter, B.
    Kranert, W. T.
    Bockisch, B.
    Lang, F. C.
    Gruenwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S344 - S345
  • [33] Exhalation of 131I after radioiodine therapy: Dosimetric considerations based on measurements in exhaled air
    Sudbrock, F.
    Fischer, Th.
    Zimmermanns, B.
    Drzezga, A.
    Schomaecker, K.
    JOURNAL OF ENVIRONMENTAL RADIOACTIVITY, 2017, 166 : 162 - 165
  • [34] Use of recombinant human thyroid-stimulating hormone (rhTSH) reduces the damage to salivary glands after radioiodine therapy for thyroid cancer
    Isoda, Takuro
    Baba, Shingo
    Maruoka, Yasuhiro
    Kitamura, Yoshiyuki
    Sasaki, Masayuki
    Honda, Hiroshi
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [35] Recurrence patterns in differentiated thyroid cancer (DTC) following adjuvant radioiodine therapy
    Ledwon, Aleksandra
    Kropinska, Aleksandra
    Paliczka-Cieslik, Ewa
    Blewaska, Aleksandra
    Sygula, Aleksandra
    Olczyk, Tomasz
    Handkiewicz-Junak, Daria
    ENDOKRYNOLOGIA POLSKA, 2024, 75 (05) : 486 - 493
  • [36] Glycididazole sodium combined with radioiodine therapy for patients with differentiated thyroid carcinoma (DTC)
    Wen, Qiang
    Ma, Qingjie
    Bai, Lin
    Wang, Tongtong
    Han, Yuping
    Zhang, Haishan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 14095 - 14099
  • [37] 18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy
    Rosenbaum-Krumme, Sandra J.
    Goerges, Rainer
    Bockisch, Andreas
    Binse, Ina
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (09) : 1373 - 1380
  • [38] 18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy
    Sandra J. Rosenbaum-Krumme
    Rainer Görges
    Andreas Bockisch
    Ina Binse
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 1373 - 1380
  • [39] Targeted therapy in patients with radioiodine-refractory differentiated thyroid cancer (DTC)
    Herceg, Davorin
    Herceg, Gordana Horvatic
    PERIODICUM BIOLOGORUM, 2014, 116 (04) : 399 - 407
  • [40] Radioiodine therapy under rhTSH for follicular thyroid carcinoma with sellar metastasis and non-rising TSH
    Taywade, Sameer Kamalakar
    Damle, Nishikant Avinash
    Kumar, Kunal
    Ranjan, Piyush
    Aggarwal, Shipra
    Bal, Chandrasekhar
    Kumar, Amandeep
    Kandasamy, Devasenathipathi
    BJR CASE REPORTS, 2016, 2 (02):
12345